Drug Profile
Enalapril liquid - Proveca
Latest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator Proveca
- Class Antihypertensives; Dipeptides; Esters; Heart failure therapies; Small molecules
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acute heart failure
Most Recent Events
- 28 Mar 2018 No recent reports of development identified for clinical-Phase-Unknown development in Acute-heart-failure(In children, In infants, In neonates) in United Kingdom (PO, Liquid)